These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2696390

  • 1. [Short term treatment of infantile pulmonary tuberculosis].
    Garciá López JR, Vidal López ML, Castán Vidal ML, Borque Andrés C, de José Gómez MI, García Hortelano J.
    An Esp Pediatr; 1989 Aug; 31(2):110-3. PubMed ID: 2696390
    [Abstract] [Full Text] [Related]

  • 2. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.
    Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281
    [Abstract] [Full Text] [Related]

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct 11; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 4. [Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis].
    Bellabas M, Khaled S, Khaled NA, Boulahbal F, Chaulet P.
    Rev Mal Respir; 1989 Oct 11; 6(1):59-64. PubMed ID: 2648511
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.
    Roy V, Tekur U, Chopra K.
    Indian Pediatr; 1996 Apr 11; 33(4):287-91. PubMed ID: 8772902
    [Abstract] [Full Text] [Related]

  • 6. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec 11; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K.
    Kekkaku; 2002 Aug 11; 77(8):569-71. PubMed ID: 12235849
    [Abstract] [Full Text] [Related]

  • 9. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK.
    Int J Tuberc Lung Dis; 1999 Feb 11; 3(2):126-32. PubMed ID: 10091877
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study].
    Eule H, Beck H, Evers H, Fischer P, Kwiatkowski H, Merkel S, Reech R, Sieler R, Thomas E, Weinecke W.
    Z Erkr Atmungsorgane; 1986 Feb 11; 167(1-2):29-41. PubMed ID: 3532585
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct 11; 78(4):330-6. PubMed ID: 6386028
    [Abstract] [Full Text] [Related]

  • 15. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R.
    Trop Med Int Health; 2005 Nov 11; 10(11):1090-8. PubMed ID: 16262733
    [Abstract] [Full Text] [Related]

  • 16. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M, Yosiyama T, Yosikawa M, Ogata H, Sugie T, Nakasono T, Sugita H.
    Kekkaku; 1994 Nov 11; 69(11):671-80. PubMed ID: 7837720
    [Abstract] [Full Text] [Related]

  • 17. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb 11; 30(2):179-83. PubMed ID: 19565883
    [Abstract] [Full Text] [Related]

  • 18. [Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].
    Mazouni L, Tazir M, Boulahbal F, Chaulet P.
    Rev Mal Respir; 1985 Feb 11; 2(4):209-14. PubMed ID: 3937189
    [Abstract] [Full Text] [Related]

  • 19. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M, Chaulet P, Darbyshire JH, Nunn A, Fox W.
    Rev Mal Respir; 1986 Feb 11; 3(2):73-85. PubMed ID: 3726263
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP, Spyridis PG, Gelesme A, Sypsa V, Valianatou M, Metsou F, Gourgiotis D, Tsolia MN.
    Clin Infect Dis; 2007 Sep 15; 45(6):715-22. PubMed ID: 17712755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.